(Q51456889)

5 April 2018

title

Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors. (English)

1 reference

5 April 2018

1 reference

Jie Zhang

1

1 reference

5 April 2018

Xiaoyan Pan

2

1 reference

5 April 2018

Chen Wang

3

1 reference

5 April 2018

Fang Wang

4

1 reference

5 April 2018

Pengfei Li

5

1 reference

5 April 2018

Wenfang Xu

6

1 reference

5 April 2018

Langchong He

7

1 reference

5 April 2018

publication date

1 March 2012

1 reference

5 April 2018

Chemical Biology and Drug Design

published in

1 reference

5 April 2018

volume

79

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

353-359

1 reference

5 April 2018

Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Using a staged multi-objective optimization approach to find selective pharmacophore models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01299.X

10.1111/J.1747-0285.2011.01299.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018